APA

Molenaar R. J., Pleyer C., Radivoyevitch T., Sidana S., Godley A., Advani A. S., Gerds A. T., Carraway H. E., Kalaycio M., Nazha A., Adelstein D. J., Nasr C., Angelini D., Maciejewski J. P., Majhail N., Sekeres M. A. & Mukherjee S. (20190219). Risk of developing chronic myeloid neoplasms in well-differentiated thyroid cancer patients treated with radioactive iodine. : Leukemia.

Chicago

Molenaar R J, Pleyer C, Radivoyevitch T, Sidana S, Godley A, Advani A S, Gerds A T, Carraway H E, Kalaycio M, Nazha A, Adelstein D J, Nasr C, Angelini D, Maciejewski J P, Majhail N, Sekeres M A and Mukherjee S. 20190219. Risk of developing chronic myeloid neoplasms in well-differentiated thyroid cancer patients treated with radioactive iodine. : Leukemia.

Harvard

Molenaar R. J., Pleyer C., Radivoyevitch T., Sidana S., Godley A., Advani A. S., Gerds A. T., Carraway H. E., Kalaycio M., Nazha A., Adelstein D. J., Nasr C., Angelini D., Maciejewski J. P., Majhail N., Sekeres M. A. and Mukherjee S. (20190219). Risk of developing chronic myeloid neoplasms in well-differentiated thyroid cancer patients treated with radioactive iodine. : Leukemia.

MLA

Molenaar R J, Pleyer C, Radivoyevitch T, Sidana S, Godley A, Advani A S, Gerds A T, Carraway H E, Kalaycio M, Nazha A, Adelstein D J, Nasr C, Angelini D, Maciejewski J P, Majhail N, Sekeres M A and Mukherjee S. Risk of developing chronic myeloid neoplasms in well-differentiated thyroid cancer patients treated with radioactive iodine. : Leukemia. 20190219.